Thalassemia clinical trials

Explore recruiting thalassemia clinical trials.

Recruiting thalassemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Thalassemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2a Study to Evaluate the Safety and Pharmacokinetics of Luspatercept (ACE-536) in Pediatric Participants with Beta (β) Thalassemia.

Italy, Greece, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label, dose-escalation, dose-finding, and proof-of-concept trial of SP-420 in subjects with transfusion-dependent α- or β-thalassemia or low-risk myelodysplastic syndromes

Denmark, Greece, Italy, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A single arm, open label, multicenter, single-dose, phase 2b clinical study evaluating efficacy and safety of gene therapy using autologous CD34+ hematopoietic stem cells transduced with the GLOBE lentiviral vector using an improved transduction protocol in subjects with transfusion-dependent beta-thalassemia.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects With Transfusion-Dependent β-Thalassemia

Germany, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Double-blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Non–Transfusion-Dependent Alpha or Beta Thalassemia (ENERGIZE)

Greece, Netherlands, Bulgaria, Denmark, Spain, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 Study for the Treatment of Anemia with Alpha (α)-Thalassemia to Determine the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) in Adults and Evaluate the Safety and Pharmacokinetics in Adolescents

Italy, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

Thalassemia trials by city

Thalassemia in Toronto Thalassemia in Vancouver Thalassemia in Montreal Thalassemia in Calgary Thalassemia in Edmonton Thalassemia in Ottawa Thalassemia in Winnipeg Thalassemia in Quebec City Thalassemia in Hamilton Thalassemia in Kitchener Thalassemia in London Thalassemia in Halifax Thalassemia in New York Thalassemia in Los Angeles Thalassemia in Chicago Thalassemia in Houston

Other conditions

Diabetic retinopathy Glaucoma Dry eye disease HIV Hepatitis B Hepatitis C COVID-19 Influenza RSV Sickle cell disease Anemia Hemophilia Chronic pain Low back pain Smoking cessation Tinnitus Hearing loss Chronic fatigue syndrome Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome